Early research (Phase 1)Study completedNCT03715634What this trial is testingStudy of a Novel Subcutaneous Depot Formulation of BuprenorphineWho this might be right forOpioid-use Disorder Indivior Inc. 12
Large-scale testing (Phase 3)Study completedNCT00706654What this trial is testingIntramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With SchizophreniaWho this might be right forSchizophrenia Otsuka Pharmaceutical Development & Commercialization, Inc. 937
Large-scale testing (Phase 3)Study completedNCT01415960What this trial is testingEfficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate CancerWho this might be right forProstate Cancer GP-Pharm 163
Large-scale testing (Phase 3)Study completedNCT00635817What this trial is testingLeuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat Central Precocious PubertyWho this might be right forPuberty, Precocious Abbott 84
Early research (Phase 1)Study completedNCT02220712What this trial is testingOpen-label Study Investigating the Pharmacokinetics and Safety of Aripiprazole IM Depot Formulation (OPC-14597 IMD) During Repeated Administration by Injection Into the Deltoid Muscle in Patients With SchizophreniaWho this might be right forSchizophrenia Otsuka Pharmaceutical Co., Ltd. 17
Large-scale testing (Phase 3)Study completedNCT00128531What this trial is testingLeuprolide Acetate 3.75 mg Depot to Treat Prostate CancerWho this might be right forProstate Cancer GP-Pharm 120